Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals Ownership Summary
Lexicon Pharmaceuticals is owned by 81.54% institutional investors, 1.15% insiders, and 17.31% retail investors. Artal group is the largest institutional shareholder, holding 37.67% of LXRX shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 6.80% of its assets in Lexicon Pharmaceuticals shares.
LXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lexicon Pharmaceuticals | 81.54% | 1.15% | 17.31% |
| Sector | Healthcare Stocks | 57.43% | 9.41% | 33.16% |
| Industry | Biotech Stocks | 69.02% | 8.92% | 22.06% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Artal group | 136.18M | 37.67% | $100.77M |
| Fmr | 51.97M | 14.38% | $38.38M |
| Siren | 38.92M | 10.77% | $28.80M |
| Blackrock | 9.89M | 4.03% | $16.62M |
| Blackrock funding, inc. /de | 10.33M | 2.86% | $7.63M |
| Vanguard group | 9.88M | 2.73% | $7.30M |
| Point72 asset management | 8.99M | 2.49% | $6.64M |
| Schonfeld strategic advisors | 7.56M | 2.09% | $5.58M |
| Nantahala capital management | 6.60M | 1.83% | $4.88M |
| Geode capital management | 3.52M | 0.97% | $2.60M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Artal group | 136.18M | 8.59% | $100.77M |
| Siren | 38.92M | 1.27% | $28.80M |
| Nantahala capital management | 6.60M | 0.21% | $4.88M |
| Ikarian capital | 1.55M | 0.16% | $1.14M |
| Virtus etf advisers | 425.27K | 0.13% | $314.06K |
| Nea management company | 2.38M | 0.10% | $1.76M |
| Tang capital management | 850.27K | 0.04% | $627.92K |
| Schonfeld strategic advisors | 7.56M | 0.03% | $5.58M |
| Rpo | 44.24K | 0.03% | $32.67K |
| Cvi | 20.00K | 0.03% | $33.60K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 8.99M | 0.01% | 7.76M |
| Schonfeld strategic advisors | 7.56M | 0.03% | 5.68M |
| Nantahala capital management | 6.60M | 0.21% | 4.30M |
| Blackrock | 9.89M | 0.00% | 2.20M |
| Fmr | 51.97M | 0.00% | 2.10M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -11.02M |
| Ameriprise financial | - | - | -2.33M |
| Opaleye management | - | - | -1.88M |
| Bvf inc/il | - | - | -1.69M |
| Cubist systematic strategies | - | - | -1.40M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ikarian capital | 1.55M | 0.16% | 1.55M | $1.14M |
| Boothbay fund management | 480.82K | 0.01% | 480.82K | $355.09K |
| Group one trading | 314.40K | 0.00% | 314.40K | $232.19M |
| Virtu financial | 88.98K | 0.00% | 88.98K | $66.00K |
| Renaissance | 51.14K | 0.00% | 51.14K | $37.77K |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -6.00 |
| Capital performance advisors llp | -18.00 |
| Tortoise investment management | -21.00 |
| Nelson, van denburg & campbell wealth management group | -21.00 |
| Rothschild investment | -75.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 122 | -12.23% | 294,769,499 | 2.13% | 81 | 1.28% | 68 | -2.86% | 20 | -4.76% |
| Sep 30, 2024 | 138 | 6.15% | 288,617,050 | 3.46% | 79 | 0.62% | 70 | -2.78% | 21 | -8.70% |
| Jun 30, 2024 | 130 | 6.56% | 278,967,822 | 61.45% | 113 | 1.86% | 72 | 9.09% | 23 | -20.69% |
| Mar 31, 2024 | 122 | 10.91% | 172,789,084 | -5.49% | 78 | 1.40% | 66 | 17.86% | 29 | 26.09% |
| Dec 31, 2023 | 110 | -3.51% | 182,824,838 | -3.14% | 74 | 0.88% | 56 | 1.82% | 23 | -20.69% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 24.57M | 6.80% | 241.29K |
| Fidelity Growth Compy Commingled Pl O | 20.40M | 5.64% | 2.23M |
| Fidelity Growth Company Fund | 16.90M | 4.67% | -345.69K |
| Fidelity Growth Company K6 | 5.50M | 1.52% | -119.19K |
| Vanguard Total Stock Mkt Idx Inv | 5.15M | 1.42% | - |
| Fidelity Series Growth Company | 4.15M | 1.15% | -405.26K |
| iShares Russell 2000 ETF | 2.99M | 0.83% | -58.55K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.90M | 0.80% | - |
| Columbia Small Cap Value I A | 1.91M | 0.53% | 497.77K |
| Biotech Growth Ord | 1.42M | 0.39% | -436.48K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
LXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools